Glycolipid depletion in antimicrobial therapy.

Glycolipid depletion in antimicrobial therapy.

Mucosal pathogens target sites of infection through specific adherence to host glycoconjugate receptors. As a consequence, depletion of such receptors from the cell surface may be expected to inhibit attachment, impair bacterial colonization and reduce the activation of mucosal inflammation. We have...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Svensson, M, Frendeus, B, Butters, T, Platt, F, Dwek, R, Svanborg, C
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	2003

समान संसाधन

Glycolipid receptor depletion as an approach to specific antimicrobial therapy.
द्वारा: Svensson, M, और अन्य
प्रकाशित: (2006)

Carbohydrate receptor depletion as an antimicrobial strategy for prevention of urinary tract infection.
द्वारा: Svensson, M, और अन्य
प्रकाशित: (2001)

Glycolipids in cell biology and medicine - Introduction
द्वारा: Dwek, R, और अन्य
प्रकाशित: (2003)

Small-molecule therapeutics for the treatment of glycolipid lysosomal storage disorders.
द्वारा: Butters, T, और अन्य
प्रकाशित: (2003)

Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy.
द्वारा: Platt, F, और अन्य
प्रकाशित: (2001)

Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
द्वारा: Jeyakumar, M, और अन्य
प्रकाशित: (2002)

Imino sugar therapy for type 1 Gaucher disease.
द्वारा: Priestman, D, और अन्य
प्रकाशित: (2000)

Contributions of Glycolipid Biosurfactants and Glycolipid-Modified Materials to Antimicrobial Strategy: A Review
द्वारा: Qin Shu, और अन्य
प्रकाशित: (2021-02-01)

CD1d presentation of glycolipids.
द्वारा: Speak, A, और अन्य
प्रकाशित: (2008)

Pharmacotherapeutic strategies using small molecules for the treatment of glycolipid lysosomal storage disorders.
द्वारा: Butters, T
प्रकाशित: (2007)

Therapeutic applications of imino sugars in lysosomal storage disorders.
द्वारा: Butters, T, और अन्य
प्रकाशित: (2003)

New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases.
द्वारा: Butters, T, और अन्य
प्रकाशित: (2003)

Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.
द्वारा: Butters, T, और अन्य
प्रकाशित: (2005)

Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders.
द्वारा: Butters, T, और अन्य
प्रकाशित: (2000)

Iminosugar inhibitors for treating the lysosomal glycosphingolipidoses
द्वारा: Butters, T, और अन्य
प्रकाशित: (2005)

Substrate reduction therapy in mouse models of the glycosphingolipidoses.
द्वारा: Platt, F, और अन्य
प्रकाशित: (2003)

Introduction
द्वारा: Dwek, R, और अन्य
प्रकाशित: (2003)

Storage solutions: treating lysosomal disorders of the brain.
द्वारा: Jeyakumar, M, और अन्य
प्रकाशित: (2005)

Glycolipids/
द्वारा: Wiegandt, H.
प्रकाशित: (1985)

Membrane disruption and cytotoxicity of hydrophobic N-alkylated imino sugars is independent of the inhibition of protein and lipid glycosylation.
द्वारा: Mellor, H, और अन्य
प्रकाशित: (2003)

Targeting glycosylation as a therapeutic approach.
द्वारा: Dwek, R, और अन्य
प्रकाशित: (2002)

N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.
द्वारा: Andersson, U, और अन्य
प्रकाशित: (2000)

Control of Alicyclobacillus acidoterrestris in Apple Juice with Natural Antimicrobial Glycolipid
द्वारा: Rory Wang, और अन्य
प्रकाशित: (2025-02-01)

Substrate reduction therapy
द्वारा: Platt, F, और अन्य
प्रकाशित: (2007)

Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipids.
द्वारा: Garner, B, और अन्य
प्रकाशित: (2002)

Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease.
द्वारा: Andersson, U, और अन्य
प्रकाशित: (2004)

The liganding of glycolipid transfer protein is controlled by glycolipid acyl structure.
द्वारा: Lucy Malinina, और अन्य
प्रकाशित: (2006-11-01)

Tuning the antimicrobial activity of microbial glycolipid biosurfactants through chemical modification
द्वारा: Melike Pala, और अन्य
प्रकाशित: (2024-02-01)

New developments in treating glycosphingolipid storage diseases.
द्वारा: Platt, F, और अन्य
प्रकाशित: (2005)

Glycosylation: disease targets and therapy.
द्वारा: Zitzmann, N, और अन्य
प्रकाशित: (2005)

High-performance cation-exchange chromatography and pulsed amperometric detection for the separation, detection, and quantitation of N-alkylated imino sugars in biological samples.
द्वारा: Mellor, H, और अन्य
प्रकाशित: (2000)

Inhibition of glycogen breakdown by imino sugars in vitro and in vivo.
द्वारा: Andersson, U, और अन्य
प्रकाशित: (2004)

Soluble human TLR2 ectodomain binds diacylglycerol from microbial lipopeptides and glycolipids.
द्वारा: Jiménez-Dalmaroni, M, और अन्य
प्रकाशित: (2015)

Glycolipids : new research /
द्वारा: Sasaki, Daiki
प्रकाशित: (c200)

Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.
द्वारा: Norris-Cervetto, E, और अन्य
प्रकाशित: (2004)

Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation.
द्वारा: Jeyakumar, M, और अन्य
प्रकाशित: (2001)

Long-term non-hormonal male contraception in mice using N-butyldeoxynojirimycin.
द्वारा: Walden, C, और अन्य
प्रकाशित: (2006)

Synergistic Treatment of Breast Cancer by Combining the Antimicrobial Peptide Piscidin with a Modified Glycolipid
द्वारा: Rebecca T. Miceli, और अन्य
प्रकाशित: (2024-07-01)

Pyroelectric detection in glycolipid thin film
द्वारा: Kwong, W.L., और अन्य
प्रकाशित: (2010)

Pharmacological impairment of acrosome formation and sperm head morphogenesis reveals essential role of glycosphingolipids in spermiogenesis
द्वारा: van der Spoel, A, और अन्य
प्रकाशित: (2002)